







 
 
  







<HTML>
<HEAD>
<TITLE>JBC --  Delmotte et al. 274 (53): 38225</TITLE>


	<SCRIPT LANGUAGE="JavaScript">
	<!--
	function startTarget(windowname,wid,hei) {
	
	var dotpos = windowname.indexOf(".");
	if (dotpos > -1)
	{
	var tempwn = windowname.substring(0,dotpos) +
		windowname.substring(dotpos + 1, windowname.length);
	windowname = tempwn;
	}
	var sizestring = 'width=' + wid + ',height=' + hei;
	window.open('',windowname,'scrollbars,resizable,' + sizestring + '\'');
	}
	// -->
	</SCRIPT>



	<!-- has inhead tag -->
	 
	 
	<script language="JavaScript">
	<!--
	if ( top != self )
	{
		top.location.href = unescape(window.location.pathname);
	}
	//-->
	</script>
	
	

<meta name="robots" content="nofollow">
</HEAD>
<BODY BGCOLOR="#FFFFFF" 
	
		
			
		
	>



<A NAME="top"><!-- null --></A>

	
	<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0">
	<TR>
		<TD VALIGN="BOTTOM" NOWRAP>
			<A TARGET="_top" STYLE="text-decoration: none" HREF="/"><IMG BORDER="0" WIDTH="220" HEIGHT="44" ALT="JBC" SRC="/icons/banner/title.gif"></A>
			<A TARGET="_top" HREF="/cgi/adclick?journal=jbc&ad=e-toc&url=http://www.jbc.org/subscriptions/etoc.shtml&side=only"><IMG BORDER=2 WIDTH=220 HEIGHT=40 SRC="/ads/gifs/908918881.gif" ALT="Email Content Delivery"></A><BR><IMG ALT="" WIDTH="1" HEIGHT="3" SRC="/icons/spacer.gif"><BR>
			
	<TABLE CELLPADDING="2" CELLSPACING="2" WIDTH="450">
	<TR>
		<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HOME</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/help/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HELP</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/cgi/feedback"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">FEEDBACK</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/subscriptions/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SUBSCRIPTIONS</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/contents-by-date.0.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">ARCHIVE</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/search.dtl"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SEARCH</FONT></A></TD>
	    


<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/content/vol274/issue53/index.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">TABLE OF CONTENTS</FONT></A></TD>




	</TR>
	</TABLE>
	</TD>
		<TD><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
		<TD VALIGN="BOTTOM">
	
	<TABLE CELLPADDING="0" CELLSPACING="1" BORDER="0" BGCOLOR="#000000"><TR>
	<FORM METHOD="GET" NAME="search" ACTION="/cgi/search"><INPUT TYPE="hidden" NAME="andorexactfulltext" VALUE="and"><INPUT TYPE="hidden" NAME="resourcetype" VALUE="1"><INPUT TYPE="hidden" NAME="disp_type" VALUE="">
	<TD ALIGN="CENTER" VALIGN="MIDDLE"> 
		<TABLE CELLPADDING="1" CELLSPACING="0" BORDER="0" BGCOLOR="#DBDBDB"> 
		<TR>
			<TD BGCOLOR="#006699"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
			<TD VALIGN="MIDDLE"  BGCOLOR="#006699" NOWRAP><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#FFFFFF"><EM>QUICK</EM> SEARCH:&nbsp;</FONT></STRONG></TD>
			<TD ALIGN="RIGHT" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A STYLE="text-decoration:none;color:#FFFFFF" HREF="/search.dtl"><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">&nbsp;[advanced]</FONT></A></TD>
			<TD BGCOLOR="#006699"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
		</TR><TR>
			<TD BGCOLOR="#DBDBDB"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
			<TD BGCOLOR="#DBDBDB" COLSPAN="2">
			<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0"> 
			<TR>
				<TD ALIGN="CENTER" VALIGN="BOTTOM"><INPUT TYPE="submit" STYLE="text-decoration:none;font-family:verdana,arial,helvetica;font-size:10px;font-weight:bold;color:#000000;background:#FFFFFF;" VALUE="Go"></TD>
				<TH ALIGN="LEFT" COLSPAN="2"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Author:<BR></FONT>
					<INPUT TYPE="text" NAME="author1" SIZE="9" MAXLENGTH="80" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TH>
				<TH ALIGN="LEFT" COLSPAN="3"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Keyword(s):<BR></FONT>
					<INPUT TYPE="text" NAME="fulltext" SIZE="16" MAXLENGTH="80" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TH>
			</TR><TR>
				<TH><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Year:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="pubdate_year" SIZE="4" MAXLENGTH="4" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
				<TH ALIGN="RIGHT"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Vol:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="volume" SIZE="4" MAXLENGTH="10" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
				<TH><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Page:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="firstpage" SIZE="4" MAXLENGTH="10" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
			</TR> 
			</TABLE> </TD>
			<TD BGCOLOR="#DBDBDB"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
		</TR>
		</TABLE></TD></FORM></TR></TABLE> 
	 
	</TD>
	</TR><TR>
		<TD COLSPAN="3"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"><BR>







	
	

	




	


	
	
	
	 

	


	
	




				<BR><FONT SIZE="-2" FACE="verdana,arial,helvetica">
	<NOBR><STRONG>Institution: Cornell University Medical College</STRONG></NOBR>
	<NOBR><A TARGET="_top" HREF="/cgi/login?uri=%2Fcgi%2Fcontent%2Ffull%2F274%2F53%2F38225">Sign In as Member/Non-Member</A></NOBR>
	
		
		
	
	</FONT>
	
 <!-- showauthstring -->
	<!-- INST -->
	<!-- INDV -->
        <!-- SPONSORED -->
	<!-- USER.PFA -->
	<!-- USER.PFABSAIC -->
	<!-- NOT GUEST -->
	

	
<HR ALIGN="LEFT" SIZE="1" COLOR="#000000" NOSHADE></TD>
	</TR>
	</TABLE>
	



         
                
        



	
		
		
	 
 





 

 
	  
		                    
	


	
		<!-- beginning of outer tables -->
               
                
                <TABLE CELLPADDING=4
                ALIGN=RIGHT
                
                CELLPADDING=5 HSPACE=4 VSPACE=4 BORDER NOWRAP>
               
		<TR><TD ALIGN=LEFT NOWRAP>

		<!-- beginning of inner table -->
				<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
		
		
	 
	
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/content/abstract/274/53/38225">Abstract of this Article</A>  (<img src="/icons/shared/toc/free.gif">)
			</FONT></TD></TR>
		
		
	


		
		
		

		
		
		


		
		
		

		
		
		

		
		
		

		
                
                

		
	


		

		
	

		
		

		
		 

		
		 
	 		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">

			
			 

			
			

						
				
				<STRONG><A HREF="/cgi/reprint/274/53/38225">Reprint (PDF) Version of this Article</A>
 				
			

			

		</FONT></TD></TR>
		
		


                
                


		


	



		



		
		

		
		
		
	


		


		

		

		
		
			
			
			
				<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/citemap?id=jbc;274/53/38225">Citation Map</A>
				</FONT></TD></TR>
		


		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/mailafriend?url=http://www.jbc.org/cgi/content/full/274/53/38225&title=Serine+157%2C+a+Retinoic+Acid+Receptor+alpha++Residue+Phosphorylated+by+Protein+Kinase+C+in+Vitro%2C+Is+Involved+in+RXR%7Bmiddle+dot%7DRARalpha++Heterodimerization+and+Transcriptional+Activity">Email this article to a friend</A>
		</FONT></TD></TR>
		


		 
		
		


	
	
	
	
		
		
		
		
	
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			Similar articles found in:<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/search?qbe=jbc;274/53/38225&journalcode=jbc&minscore=5000"><FONT SIZE="-1">JBC Online</FONT></A>
				
				
				<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/external_ref?access_num=10608897&link_type=MED_NBRS"><FONT SIZE="-1">PubMed</FONT></A>
		</FONT></TD></TR>
		
		
	
	
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/external_ref?access_num=10608897&link_type=PUBMED">PubMed Citation</A>
	</FONT></TD></TR>
	
	

		
		
		
		
		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				This Article has been cited by:
			</FONT></TD></TR>
		

		
		
		
		<TR><TD><FONT SIZE="-1">
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="#otherarticles">other online articles</A>
		</FONT></TD></TR>
		


                
                


                
                

		
		
		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		
			Search PubMed for articles by:<BR>
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">
			
				<A HREF="/cgi/external_ref?access_num=Delmotte+MH&link_type=AUTHORSEARCH">Delmotte, M.-H.</A>
				 || 
			
				<A HREF="/cgi/external_ref?access_num=Lefebvre+P&link_type=AUTHORSEARCH">Lefebvre, P.</A>
				
			
		
		</FONT></TD></TR>
		

		
		



		



		


		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		Alert me when:
		<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&saveAlert=no&cited_by_criteria_resid=jbc;274/53/38225&return_type=article&return_url=%2Fcgi%2Fcontent%2Ffull%2F274%2F53%2F38225"><FONT SIZE="-1">new articles cite this article</FONT></A><BR>
		</FONT></TD></TR>


		


		
		


		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			<A HREF="/cgi/citmgr?gca=jbc;274/53/38225">Download to Citation Manager</A>
		</FONT></TD></TR>
		
		

		
		</TABLE> 
		</TD></TR> <!-- end of inner content box -->




		
		
		
		


		
        <!-- 1xxx --><!-- 2xxx --><!-- 3xxx -->
        
	</TABLE>	 <!-- end of outer content box -->
	


	









 





	
	
	
	
	
	
	
	
	
		<vardef id="TEXT">
<!--

   Pages created by the Electronic Press Engine from

		Atypon Systems, Inc.

   Visit http://www.atypon.com/

-->


<P>
<FONT SIZE=-1>J Biol Chem, Vol. 274, Issue 53, 38225-38231, December 31, 1999</FONT><BR>




<H2>
<FONT COLOR=A70716 SIZE=-1>

</FONT>

    <BR>
    Serine 157,&nbsp;a Retinoic Acid Receptor <IMG SRC="/math/12pt/Large/alpha.gif" ALIGN=BASELINE ALT="alpha ">&nbsp;Residue Phosphorylated
by Protein Kinase C <I>in Vitro</I>, Is Involved in RXR&#183;RAR<IMG SRC="/math/12pt/Large/alpha.gif" ALIGN=BASELINE ALT="alpha ">
Heterodimerization and Transcriptional Activity<A HREF="#FN150"><SUP>*</SUP></A>


</H2>



<STRONG>
<NOWRAP>
Marie-H&eacute;l&egrave;ne 
Delmotte<A HREF="#FN152"><SUP><IMG SRC="/math/12pt/normal/scr/link/Dagger.gif" ALIGN=BASELINE ALT="Dagger " BORDER=0></SUP></A>,<WBR>
Ali 
Tahayato<A HREF="#FN153"><SUP>&#167;</SUP></A>,<WBR>
Pierre 
Formstecher, and<WBR>
Philippe 
Lefebvre<A HREF="#FN154"><SUP>&#182;</SUP></A>
</NOWRAP>
</STRONG>
<P>
From INSERM Unit&eacute; 459,&nbsp;Facult&eacute; de M&eacute;decine Henri
Warembourg, 1,&nbsp;place de Verdun, 59045&nbsp;Lille cedex, France
<P>






    
	
	    
	
	    
		
    
	
	    
	
    
	
	    
	
    
    
	
	    
	
    







<a name = "Abstract"><!-- comment for mosaic --></a>



<A NAME="Abstract"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ABSTRACT</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>ABSTRACT</FONT>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>

<P>Retinoic acid (RA) regulation of cellular
proliferation and differentiation is mediated, at least in part,
through two related<SUP> </SUP>nuclear receptors, RAR</A> and RXR</A>. RA-induced
modulation of gene<SUP> </SUP>expression leads generally to cellular
differentiation, whereas<SUP> </SUP>stimulation of the protein kinase C (PKC</A>)
signaling pathway is<SUP> </SUP>associated with cellular proliferation. Pursuant
to our discovery<SUP> </SUP>that prolonged activation of PKCs induced a strong
decrease in<SUP> </SUP>RA responsiveness of a retinoid-inducible reporter gene, we
have<SUP> </SUP>further investigated the connections between these two signaling<SUP> </SUP>pathways. We demonstrate that PKC</A> isoforms <IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">&nbsp;and <IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">&nbsp;are able to<SUP> </SUP>phosphorylate human RAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> (hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">) <I>in vitro</I> on a single
serine residue<SUP> </SUP>located in the extended DNA binding domain (T box). The
introduction<SUP> </SUP>of a negative charge at this position (serine 157)
strongly decreased<SUP> </SUP>hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> transcriptional activity, whereas a similar
mutation at<SUP> </SUP>other PKC</A> consensus phosphorylation sites had no effect.
The effect<SUP> </SUP>on transcriptional activation was correlated with a decrease
in<SUP> </SUP>the capacity of hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> to heterodimerize with hRXR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">. Thus hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUP> </SUP>is a direct target for PKC<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> and <IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">, which may control retinoid<SUP> </SUP>receptor transcriptional activities during cellular proliferation<SUP> </SUP>and<SUP> </SUP>differentiation.
<BR><BR CLEAR=ALL>




<TXT>
<A NAME="SEC0"><!-- comment for mosaic --></A>

    
    

    
    

    
    
	
	
	
<A NAME="Introduction"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;INTRODUCTION</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>INTRODUCTION</FONT>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>

    

<P>External stimuli (neurotransmitters, hormones, mitogens)
activating G-protein-coupled receptors and growth factor receptors<SUP> </SUP>induce the activity of phospholipases, which in turn generate<SUP> </SUP>membrane
lipid metabolites. Among them, diacylglycerol
(DAG</A>)<SUP>1</SUP> and others are able to
modulate cellular protein kinase C (PKC</A>)<SUP> </SUP>activities needed for
sustained cellular responses (<A HREF="#B1">1</A>, <A HREF="#B2">2</A>).<SUP> </SUP>The PKC</A> superfamily contains to
date 11&nbsp;isoforms encoded by 10<SUP>&nbsp;</SUP>genes. The isoforms can be classified
into three groups based<SUP> </SUP>on sequence homologies and biochemical
properties: conventional<SUP> </SUP>PKCs (isoforms <IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">, <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1, <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">2, and <IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">) are
DAG</A>- and calcium-dependent<SUP> </SUP>kinases; novel PKCs (isoforms
<IMG SRC="/math/12pt/normal/delta.gif" ALIGN=BASELINE ALT="delta ">, <IMG SRC="/math/12pt/normal/epsilon.gif" ALIGN=BASELINE ALT="epsilon ">, <IMG SRC="/math/12pt/normal/eta.gif" ALIGN=BASELINE ALT="eta ">, <IMG SRC="/math/12pt/normal/theta.gif" ALIGN=BASELINE ALT="theta ">) are dependent only on<SUP> </SUP>DAG</A>; and a third group of
atypical PKCs (isoforms <IMG SRC="/math/12pt/normal/xi.gif" ALIGN=BASELINE ALT="xi ">, <IMG SRC="/math/12pt/normal/lambda.gif" ALIGN=BASELINE ALT="lambda ">/<IMG SRC="/math/12pt/normal/iota.gif" ALIGN=BASELINE ALT="iota ">) is unresponsive<SUP> </SUP>to DAG</A> and
calcium. The&nbsp;&#181;&nbsp;isoform (mouse protein kinase D) is<SUP> </SUP>a high molecular
weight enzyme with specific properties such as<SUP> </SUP>a transmembrane domain,
but it can be considered an atypical PKC</A><SUP> </SUP>in view of its very low
affinity for DAG</A> (for review, see Refs.<SUP> </SUP><A HREF="#B3">3</A> and <A HREF="#B4">4</A>). All of these kinases
need negatively charged phospholipids<SUP> </SUP>(phosphatidylserine) to exert
their phosphorylating activities,<SUP> </SUP>triggering major cellular events such
as differentiation and proliferation.<SUP> </SUP>Although a clear physiological
role for each isozyme has not been<SUP> </SUP>established definitively, the
existence of these isotypes with<SUP> </SUP>unique subcellular and tissue
distribution suggests a specialized<SUP> </SUP>role for each isoform (for review,
see Ref. <A HREF="#B5">5</A>). Most notably,<SUP> </SUP>gene transfer experiments have underlined a
role of these protein<SUP> </SUP>kinases in cellular proliferation and tumor
growth<SUP> </SUP>progression.
</P>
<P>Nuclear receptors are ligand-dependent transcription
factors that control a wide range of cellular events, including
cellular<SUP> </SUP>proliferation and differentiation. Several lines of evidence
point<SUP> </SUP>to a direct role of the PKC</A> signaling pathway in modulating the<SUP> </SUP>transcriptional activity of some members of this superfamily.<SUP> </SUP>The
thyroid hormone receptor appears to be a target for PKC</A> (<A HREF="#B6">6</A>)<SUP> </SUP>as well as
the human vitamin D receptor (hVDR). hVDR is phosphorylated<SUP> </SUP>by PKC<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">
in the DNA binding domain (DBD</A>), and phosphorylated serine<SUP> </SUP>(Ser-51) is
important for hVDR transactivation properties (<A HREF="#B7">7</A>,<SUP> </SUP><A HREF="#B8">8</A>). Regulation of
other nuclear receptors (glucocorticoid receptor,<SUP> </SUP>peroxisome
proliferator-activated receptor, estrogen receptor)<SUP> </SUP>through activation
of the MAP</A> kinase cascade has also been documented<SUP> </SUP>and suggests that
PKC</A>, as an activator of the MAP</A> kinase pathway,<SUP> </SUP>might participate
indirectly in the control of the transcriptional<SUP> </SUP>activity of these
nuclear receptors (<A HREF="#B9">9-13</A>).
</P>
<P>Our previous experiments pointed to a role of PKC</A> in the regulation of
hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> transcriptional activity. They indicated that<SUP> </SUP>chronic treatment
of COS-7 cells with TPA</A> led to the specific<SUP> </SUP>inhibition of the activity
of a retinoid-inducible reporter gene.<SUP> </SUP>We determined that hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> is a
substrate for PKC</A> <I>in vitro</I>, and<SUP> </SUP>preliminary results
suggested that two to four phosphorylation<SUP> </SUP>sites occurred out of the
ligand binding domain (LBD</A>) of this<SUP> </SUP>nuclear receptor (<A HREF="#B14">14</A>). In light of
these results, we addressed<SUP> </SUP>in this study several questions to
elucidate further the role<SUP> </SUP>of PKC</A> isozymes in the regulation of the
transcriptional activity<SUP> </SUP>of hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">. We characterized PKC</A> isoforms for
their capacity to<SUP> </SUP>phosphorylate hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> <I>in vitro</I> and
identified the target amino acid.<SUP> </SUP>Mutation of the phosphorylated serine
affected hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> transcriptional<SUP> </SUP>activity, and the molecular basis for
the observed inhibition<SUP> </SUP>was investigated. Our results support the
hypothesis that PKC<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUP> </SUP>and PKC<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma "> are direct regulators of hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">
transcriptional activity<SUP> </SUP>by altering its ability to dimerize with<SUP> </SUP>RXRs.
<BR><BR CLEAR=ALL>



<A NAME="SEC1"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;EXPERIMENTAL PROCEDURES</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>EXPERIMENTAL PROCEDURES</FONT>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    



    



    


<P><I>Materials--</I>

TPA</A> and atRA</A> were obtained from Sigma (Saint
Quentin Fallavier, France). Purified rat brain PKC</A> was purchased from
Calbiochem-Novabiochem<SUP> </SUP>Corp. (Meudon, France).
[<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">-<SUP>32</SUP>P]ATP (3,000&nbsp;Ci/mmol), the ECLplus detection kit,
and polyvinylidene<SUP> </SUP>difluoride transfer membranes were from Amersham
Pharmacia Biotech<SUP> </SUP>(Les Ulis, France). DNA restriction and modifications
enzymes<SUP> </SUP>were from Promega (Charbonnieres, France). Site-directed
mutagenesis<SUP> </SUP>reactions were carried out using the QuickChange system
from Stratagene<SUP> </SUP>(San Diego, CA). Polyethyleneimine (ExGen 500) was from
EuroMedex<SUP> </SUP>(Souffelweyersheim, France). Oligonucleotides were purchased
from<SUP> </SUP>Eurogentec (Le Sart-Tilman,<SUP> </SUP>Belgium).



    

    


<P><I>Plasmids--</I>

Constructs containing either the wild-type (wt</A>)
hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> and wt</A> hRXR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> cDNAs subcloned into pSG5 (Stratagene) or
pQE9 (Qiagen,<SUP> </SUP>Diagen Gmbh, Dusseldorf, Germany). ) have been described
in (<A HREF="#B15">15</A>,<SUP> </SUP><A HREF="#B16">16</A>). Mutations at potential phosphorylation sites were
generated<SUP> </SUP>using the appropriate oligonucleotide that contained the
desired<SUP> </SUP>mutation and a silent mutation introducing or inactivating a
restriction<SUP> </SUP>site. The following mutagenic primers were used in this
study<SUP> </SUP>(parentheses indicate the new restriction site, mutations are<SUP> </SUP>indicated in bold<SUP> </SUP>characters).
<P>
S115G: 5'-ggcttcttccgccgc<U><B><I>g</I></B></U>gcatccagaagaacatg-3'
(<I>Sac</I>II);
<P>
S115D:
5'-cgccgc<U><B><I>ga</I></B></U>catccagaagaacatggtgtacacgtgtcaccgggacaagaactgcatcatcaacaaggtgac<U><B><I>t</I></B></U>cggaaccgc-3'<SUP> </SUP>(<I>Bst</I>EII);
<P>
S154A:
5'-gaagtgggcatg<U><B><I>g</I></B></U>ccaaggagtctgtgagaaacga<U><B><I>t</I></B></U>cgaaacaagaagaag-3'
(<I>Pvu</I>I);
<P>
S157A:
5'-atgtccaaggag<U><B><I>g</I></B></U>ctgtgagaaacga<U><B><I>t</I></B></U>cgaaacaagaagaag-3'
(<I>Pvu</I>I);
<P>
S154A,S157A: 5'-
gccgactgcagaagtgctt<U><B><I>c</I></B></U>gaagtgggcatg<U><B><I>g</I></B></U>ccaaggag<U><B><I>g</I></B></U>ctgtgagaaacgaccg-3'<SUP> </SUP>(<I>Xmn</I>I);
<P>
S154D:
5'-ac<U><B><I>t</I></B></U>cggaaccgctgccagtactgccgactgcagaagtgctttgaagtgggcatg<U><B><I>ga</I></B></U>cgtgagaaac-3'
(<I>Bst</I>EII);
<P>
S157D:
5'-atgtccaaggag<U><B><I>g</I></B></U>ctgtgagaaacggacgaaacaagaagaag-3'
(<I>Pvu</I>I);
<P>
S154D,S157D:
5'-atgtccaaggag<U><B><I>g</I></B></U>ctgtgggcatg<U><B><I>gac</I></B></U>aaggag<U><B><I>gat</I></B></U>gtgagaaac-3'
(<I>Pvu</I>I);
<P>
S232A:
5'-gggacaagttcagtga<U><B><I>g</I></B></U>ctc<U><B><I>g</I></B></U>c<U><B><I>t</I></B></U>accaagtgcatc-3'
(<I>Sac</I>I);
<P>
S232D:
5'-cgtgtctctct<U><B><I>a</I></B></U>gacattgacctctgggacaagttcagttcagtgaactcg<U><B><I>c</I></B></U>cacctcgcc-3'
(<I>Xba</I>I);
<P>
S388A:
5'-gaagattactgacctg<U><B><I>a</I></B></U>g<U><B><I>g</I></B></U>agcatc<U><B><I>gc</I></B></U>cgccaagggggctgagcggg-3'
(<I>Bsu</I>36I);
<P>
S388D:
5'-gaagattacctgacctg<U><B><I>a</I></B></U>ggagcatc<U><B><I>ga</I></B></U>cgccaagggggctgagcggg-3'
(<I>Bsu</I>36I);
<P>
S452A:
5'-ccaggcagctgtagccc<U><B><I>a</I></B></U>agc<U><B><I>t</I></B></U>t<U><B><I>a</I></B></U>agccccagc<U><B><I>g</I></B></U>ccaacagaagcagccc-3'<SUP> </SUP>(<I>Hin</I>dII);
<P>
S452D:
5'-gccaggcagctg<U><B><I>c</I></B></U>agccccagcctcagccccagc<U><B><I>ga</I></B></U>caacagaagcagcc-3'
(<I>Pst</I>I).
<P>
All mutations were checked by restriction analysis and automatic
sequencing. Detailed sequence information is available upon<SUP> </SUP>request.



    

    


<P><I>Cell Culture and Transfections--</I>

HeLa cells were cultured as
monolayers in Dulbecco's minimal essential medium supplemented with
10% fetal calf serum. Cells<SUP> </SUP>were treated when indicated with TPA</A>
and/or retinoids to a final<SUP> </SUP>concentration of 10<SUP><IMG SRC="/math/12pt/normal/scr/minus.gif" ALIGN=BASELINE ALT="-">7</SUP>
<font size=-1>M</font> and 10<SUP><IMG SRC="/math/12pt/normal/scr/minus.gif" ALIGN=BASELINE ALT="-">6</SUP> <font size=-1>M,</font> respectively.
Transfections were carried out using the polyethyleneimine<SUP> </SUP>coprecipitation method as described (<A HREF="#B17">17</A>). The luciferase assay<SUP> </SUP>was
performed as described (<A HREF="#B15">15</A>).



    

    


<P><I>Receptor Purification and Phosphorylation Analysis--</I>

A
detailled procedure has been published elsewhere (<A HREF="#B18">18</A>). Briefly,
His<SUB>6</SUB>-hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> was overexpressed in <I>Escherichia
coli</I> and purified<SUP> </SUP>to homogeneity by nickel-immobilized affinity
chromatography.<SUP> </SUP>The purified polypeptide was phosphorylated and
purified further<SUP> </SUP>by 8% SDS-PAGE. Gel slices containing the
phosphorylated receptor<SUP> </SUP>were desiccated and rehydrated with trypsin
digestion buffer,<SUP> </SUP>and trypsin was added to a 1:50 (w:w) ratio. Peptides
were extracted<SUP> </SUP>and purified on a C18 column and submitted to Edman
degradation<SUP> </SUP>reaction for sequencing. Phosphoamino acid determination
was as<SUP> </SUP>follows. The phosphorylated hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> was purified by 8% SDS-PAGE<SUP> </SUP>and transfer onto a polyvinylidene difluoride membrane. Bands<SUP> </SUP>containing the radioactive receptor were cut out and transferred<SUP> </SUP>into
an Eppendorf tube containing 200&nbsp;&#181;l of 5.7&nbsp;<font size=-1>N</font> HCl. After a<SUP> </SUP>1-h incubation at 110&nbsp;&#176;C, the hydrolysate was dried and resuspended<SUP> </SUP>in 20&nbsp;&#181;l of electrophoresis buffer (0.5% acetic acid, 0.5% pyridine<SUP> </SUP>at pH 3.5). 10&nbsp;&#181;g of phosphoserine, phosphothreonine, and
phosphotyrosine<SUP> </SUP>(Sigma) were added to the sample, which was submitted
to electrophoresis<SUP> </SUP>on a cellulose glass-backed plate for 30&nbsp;min at
1,000&nbsp;V (30&nbsp;mA).<SUP> </SUP>Plates were then dried and sprayed with ninhydrin to
locate phosphoamino<SUP> </SUP>acid standard. <SUP>32</SUP>P-Labeled amino acids
were identified by<SUP> </SUP>autoradiography.



    

    


<P><I>Western Blotting and Antibodies--</I>

Antibodies directed against
isoforms of PKC</A> were obtained from Transduction Laboratories
(Lexington, KY). The anti-MRGS(His)<SUB>6</SUB><SUP> </SUP>and
anti-(His)<SUB>5</SUB> monoclonal antibodies were purchased from
Qiagen.<SUP> </SUP>The anti-RAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> monoclonal antibody was from Affinity
BioReagents<SUP> </SUP>(Neshanic Station, NJ). Peroxidase-coupled anti-mouse and
anti-rabbit<SUP> </SUP>IgGs were from Sigma. Immunodetections were carried out as
described<SUP> </SUP>previously using the Amersham ECLplus detection system.
SDS-PAGE,<SUP> </SUP>electrotransfer of proteins, and immunodetection procedures
have<SUP> </SUP>been described in Ref. <A HREF="#B14">14</A>.



    

    


<P><I>Protein-Protein Interaction Assays--</I>

Protocols for
glutathione <I>S</I>-transferase pull-down experiments have been
described elsewhere (<A HREF="#B17">17</A>, <A HREF="#B19">19</A>). Matrix-bound receptors<SUP> </SUP>were then resolved
by 8% SDS-PAGE and detected by autoradiography<SUP> </SUP>or quantified using a
Storm PhosphorImager (Molecular Dynamics).<SUP> </SUP>The RXR</A> binding assay used
in Fig. <a href="#F6">6</a><I>B</I> was carried out as described<SUP> </SUP>in Ref. <A HREF="#B16">16</A>. Briefly,
native or PKC-phosphorylated purified His<SUB>6</SUB>-hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUP> </SUP>was
diluted to a final concentration of 20&nbsp;&#181;g/ml in 1&nbsp;&#215;&nbsp;phosphate-buffered<SUP> </SUP>saline and adsorbed (~&nbsp;0.5&nbsp;&#181;g/well) to a Corning
96-well tissue<SUP> </SUP>culture-treated plate for 16&nbsp;h at 4&nbsp;&#176;C. Wells
were then washed<SUP> </SUP>three times with 1&nbsp;&#215;&nbsp;phosphate-buffered saline
and coated for<SUP> </SUP>3&nbsp;h with a 5% fetal calf serum solution in 1&nbsp;&#215;&nbsp;phosphate-buffered<SUP> </SUP>saline to saturate nonspecific binding sites.
Wells were washed<SUP> </SUP>three times with 1&nbsp;&#215;&nbsp;phosphate-buffered saline,
and 10<SUP>6</SUP> cpm of <SUP>35</SUP>S-labeled hRXR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> was loaded
into each well and incubated for 90<SUP>&nbsp;</SUP>min at 4&nbsp;&#176;C in 30&nbsp;&#181;l of
binding buffer (20&nbsp;m<font size=-1>M</font> HEPES, pH 7.8,&nbsp;130<SUP>&nbsp;</SUP>m<font size=-1>M</font>
KCl, 1&nbsp;m<font size=-1>M</font> EDTA, 1&nbsp;m<font size=-1>M</font> <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-mercaptoethanol,
0.05% Nonidet P-40,<SUP> </SUP>and 20% glycerol). Unbound hRXR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> was removed by
four washes with<SUP> </SUP>ice-cold binding buffer, and the specifically adsorbed
<SUP>35</SUP>S-labeled hRXR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> was released by incubation with 50&nbsp;&#181;l
of 0.1%<SUP> </SUP>SDS, 0.4&nbsp;<font size=-1>M</font> HCl. Radioactivity was quantified by
scintillation<SUP> </SUP>counting. Protein assays were carried out according to
Bradford<SUP> </SUP>(<A HREF="#B20">20</A>) using bovine serum albumin as a<SUP> </SUP>standard.



    

    


<P><I>Statistical Analysis--</I>

All incubations or assays were
performed at least in triplicate. Measured values were used to
calculate a mean&nbsp;&#177;&nbsp;S.E., and<SUP> </SUP>groups of data were compared using a
two-sided analysis of variance<SUP> </SUP>test followed by a Dunnett test.
Significance was defined as <I>p</I><SUP>&nbsp;</SUP>&lt;&nbsp;than 0.01.&nbsp;Calculations were carried out using the Prism software<SUP> </SUP>(GraphPad Inc.,
San Diego,<SUP> </SUP>CA).



    


    


    
    


<BR><BR CLEAR=ALL>


<A NAME="SEC2"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;RESULTS</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>RESULTS</FONT>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    



    



    


<P><I>hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> Is Phosphorylated by PKC<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> and PKC<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma "> on Serine Residues
in Vitro--</I>

We reported previously that one or two amino acids in
the hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> sequence located outside of the LBD</A> were phosphorylated by<SUP> </SUP>PKCs purified from rat brain (<A HREF="#B14">14</A>). We thus determined which<SUP> </SUP>isoforms of
PKC</A> were present in these commercial preparations<SUP> </SUP>by Western blotting
analysis using a panel of isozyme-selective<SUP> </SUP>monoclonal antibodies. We
found that rat brain extracts contained<SUP> </SUP>exclusively the PKC<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> and <IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">&nbsp;isoforms, with trace amounts of the<SUP>&nbsp;</SUP>&#181;&nbsp;isoform (Fig.
<a href="#F1">1</a><I>A</I>). Using this protein kinase
mixture in an <I>in<SUP> </SUP>vitro</I> phosphorylation reaction with
purified His<SUB>6</SUB>-tagged hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUP> </SUP>as a substrate, we found that
this receptor was a substrate for<SUP> </SUP>PKCs, as reported previously (Fig.
<a href="#F1">1</a><I>B</I>). PKCs were able, in these<SUP> </SUP>conditions, to display
autophosphorylating activity as documented<SUP> </SUP>previously (for review, see
Ref. <A HREF="#B21">21</A>), but no kinase activity<SUP> </SUP>was detected in purified hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">
preparations. The PKC-catalyzed<SUP> </SUP>hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> phosphorylation was inhibited
by GF109203X, a specific but<SUP> </SUP>general inhibitor of PKCs, and by an
inhibitor specific for <IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">,<SUP> </SUP><IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">, and <IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">&nbsp;isoforms (G&ouml;6976; Ref.
<A HREF="#B22">22</A>). G&ouml;6976 strongly inhibited<SUP> </SUP>PKC-directed phosphorylation of
hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">, but phosphate incorporation<SUP> </SUP>was still detectable, suggesting
that PKC&#181; may display some weak<SUP> </SUP>phosphorylating activity in these
conditions. From these experiments,<SUP> </SUP>we conclude that PKC<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> and/or
PKC<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma "> is the most active isozyme phosphorylating<SUP> </SUP>hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> <I>in
vitro</I>.



<BR CLEAR=ALL><A NAME="F1"><!-- FIG 1 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/274/53/38225/F1">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=198 HEIGHT=200 SRC="/content/vol274/issue53/images/small/bc0103913001.gif"></A><BR>

<STRONG>View larger version</STRONG> (70K):
<BR><NOBR><A HREF="/cgi/content/full/274/53/38225/F1">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/274/53/38225/F1"
onClick="startTarget('F1', 586, 640); this.href='/cgi/content-nw/full/274/53/38225/F1'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F1">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 1. &nbsp;</STRONG>

<B>Phosphorylation of hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">
by PKCs <I>in vitro.</I></B> <I>Panel A</I>, identification
of PKC</A> isoforms purified from rat brain. 1&nbsp;ng of purified
rat brain PKC</A> (Calbiochem) was fractionated by 8% SDS-PAGE and blotted
on a polyvinylidene difluoride membrane. Immunodetection of each
isoform was carried out using specific monoclonal antibodies as
described under "Experimental Procedures." Molecular masses are
indicated on the <I>left. Panel B</I>, hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> is
phosphorylated by PKC<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> and PKC<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma "> <I>in vitro</I>.
His<SUB>6</SUB>-tagged hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> was purified to near homogeneity from
<I>E.&nbsp;coli</I> extracts using NiTA affinity chromatography and
incubated with purified rat brain PKCs and [<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">-<SUP>32</SUP>P]ATP,
in the presence of a PKC</A> inhibitor (100&nbsp;n<font size=-1>M</font> GF109203X) or an
inhibitor specific for <IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">, <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">, and <IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">&nbsp;isoforms (100&nbsp;n<font size=-1>M</font>
G&ouml;6976). Phosphorylated proteins were analyzed by 8% SDS-PAGE,
and gels were either silver stained (<I>left panel</I>) or
autoradiographed (<I>right panel</I>). <I>Panel C</I>, PKC<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">
and PKC<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma "> phosphorylate hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> on serine residues. hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> was
phosphorylated by rat brain PKCs and gel purified as in <I>panel
B</I>. The polypeptide was submitted to total acid hydrolysis, and
reaction products were separated by thin layer chromatography and
identified by comigration with phosphoamino acid standards.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 1 -->




<P>
Phosphorylated hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> was gel purified and submitted to acid
hydrolysis to determine which type of amino acid was phosphorylated<SUP> </SUP>in
these conditions. Products were analyzed by thin layer chromatography<SUP> </SUP>and identified by comigration with phosphoamino acid standards<SUP> </SUP>(Fig.
<a href="#F1">1</a><I>C</I>). Only phosphoserine was detected in these conditions,<SUP> </SUP>suggesting that hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> is phosphorylated by PKC</A> only on serine(s)<SUP> </SUP>located outside of the LBD</A>.



    

    


<P><I>Identification of Serine Residues Phosphorylated in Vitro by PKC<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">
and PCK<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">--</I>

To identify hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> amino acids phosphorylated by
PKC<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> and <IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">&nbsp;isoforms further, we submitted the purified, denatured,
phosphorylated<SUP> </SUP>receptor to trypsin digestion. Proteolysis products were
fractionated<SUP> </SUP>by reverse phase high performance liquid chromatography,
and two<SUP> </SUP>labeled peptides (Fig.
<a href="#F2">2</a><I>B</I>) were reproducibly detected
in these<SUP> </SUP>conditions, albeit in varying
ratio.<A HREF="#FN2"><SUP>2</SUP></A> These peptides were
NH<SUB>2</SUB>-terminally sequenced by the Edman reaction.<SUP> </SUP>Peak I
corresponded to the sequence (K)<SUP>148</SUP>CFEVGMS, whereas peak II
was identified as peptide (R)<SUP>139</SUP>CQYCRLQ. The occurrence of
lysine (K) and of arginine (R) upstream<SUP> </SUP>of the cleavage site in the
primary sequence of hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> identified<SUP> </SUP>these peptides as products of
trypsin cleavage. These results<SUP> </SUP>indicated, however, that partial
tryptic digests were generated<SUP> </SUP>in our conditions but nevertheless
mapped phosphorylated serine(s)<SUP> </SUP>to the same region of the DBD</A>, spanning
the T and A boxes. A PKC</A><SUP> </SUP>consensus phosphorylation site is found at
position 157.&nbsp;Because<SUP> </SUP>partial proteolysis was likely, Ser-154 remained
a possible target<SUP> </SUP>for PKC-catalyzed phosphorylation, although this
amino acid is<SUP> </SUP>not surrounded by amino acids usually defining a
PKC-directed<SUP> </SUP>phosphorylation site (R<I>XX</I>S/T<I>X</I>R).
Thus we converted Ser-157 and<SUP> </SUP>Ser-115, Ser-154, Ser-232, and Ser-388
into an alanine (A) to<SUP> </SUP>determine whether these serine residues could be
minor phosphorylation<SUP> </SUP>sites undetected in our phosphopeptide mapping
experiments. His-tagged<SUP> </SUP>wt</A> and mutated hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> were expressed in
bacteria, purified by immobilized<SUP> </SUP>metal affinity chromatography, and
tested for their ability to<SUP> </SUP>serve as a substrate for PKC</A>.
Phosphorylation reactions were carried<SUP> </SUP>out as described above, using an
identical amount of each receptor<SUP> </SUP>derivative, and products were
subjected to SDS-PAGE. Receptor<SUP> </SUP>concentrations were controlled by
silver staining (Fig. <a href="#F3">3</a>, <I>left<SUP> </SUP>panels</I>) of gels, which were then dried and autoradiographed (Fig.<SUP> </SUP><a href="#F3">3</a>, <I>right panels</I>). We found that only mutation of Ser-157
severely<SUP> </SUP>compromised PKC-catalyzed phosphorylation, whereas all other
substitutions<SUP> </SUP>designed to inactivate other consensus sequences had no
significant<SUP> </SUP>effect on the phosphate content of hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">. Residual
phosphate incorporation<SUP> </SUP>was, however, observed with the S157A mutant,
suggesting that<SUP> </SUP>other sites may represent poor substrates for PKC</A>.
Alternatively,<SUP> </SUP>this residual activity might result from contaminating,
unidentified<SUP> </SUP>protein kinases in the rat brain extract. Thus Ser-157
appeared<SUP> </SUP>to be the major target for PKC</A> <I>in vitro,</I> and these
data support<SUP> </SUP>both peptide mapping results and our previous conclusion
that<SUP> </SUP>putative phosphorylation site(s) lie outside of the LBD</A> (<A HREF="#B14">14</A>).<SUP> </SUP>Ser-157 is located in the DBD</A> of the receptor, in a region lying<SUP> </SUP>COOH-terminally of the second zinc finger motif. Sequence alignment<SUP> </SUP>between RAR</A> and RXR</A> isoforms showed that Ser-157 is found only<SUP> </SUP>in
RAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> and RAR<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> (Fig. <a href="#F4">4</a>) and is located
in the so-called T box<SUP> </SUP>region, which has been reported to be important
for dimerization<SUP> </SUP>and DNA binding activities of several nuclear
receptors (<A HREF="#B23">23</A>,<SUP> </SUP><A HREF="#B24">24</A>).



<BR CLEAR=ALL><A NAME="F2"><!-- FIG 2 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/274/53/38225/F2">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=149 HEIGHT=200 SRC="/content/vol274/issue53/images/small/bc0103913002.gif"></A><BR>

<STRONG>View larger version</STRONG> (24K):
<BR><NOBR><A HREF="/cgi/content/full/274/53/38225/F2">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/274/53/38225/F2"
onClick="startTarget('F2', 477, 640); this.href='/cgi/content-nw/full/274/53/38225/F2'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F2">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 2. &nbsp;</STRONG>

<B>Identification of </B><B>PKC</B></A><B> phosphorylation sites
along the hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> primary sequence.</B> hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">
was used as a substrate for purified PKCs and gel purified as above.
The denaturated polypeptide was then digested with TPCK-treated
trypsin, and cleaved peptides were fractionated on a C18 reverse phase
HPLC column. Peptides were identified by monitoring OD at 225&nbsp;nm
(<I>panel A</I>), and phosphorylated species were localized by
quantifying radioactivity in each fraction (<I>panel B</I>).
Fractions containing phosphorylated peptides (I and II) were
lyophilized and subjected to automatic Edman degradation. The first
radioactive peak (<I>panel B</I>) corresponds to unbound
radioactivity, and the <I>dotted lines</I> indicate the
acetonitrile concentration in percent (<I>right axis</I>).


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 2 -->







<BR CLEAR=ALL><A NAME="F3"><!-- FIG 3 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/274/53/38225/F3">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=103 SRC="/content/vol274/issue53/images/small/bc0103913003.gif"></A><BR>

<STRONG>View larger version</STRONG> (61K):
<BR><NOBR><A HREF="/cgi/content/full/274/53/38225/F3">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/274/53/38225/F3"
onClick="startTarget('F3', 590, 426); this.href='/cgi/content-nw/full/274/53/38225/F3'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F3">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 3. &nbsp;</STRONG>

<B>Mutation of serine 157&nbsp;prevents
phosphorylation of hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> by PKCs.</B>
Wild-type or mutated hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> was overexpressed in <I>E.&nbsp;coli</I>
and purified by NiTA chromatography. Each receptor was submitted to a
phosphorylation reaction in the presence of [<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">-<SUP>32</SUP>P]ATP
and PKCs from rat brain. Samples were resolved by 8% SDS-PAGE, gels
were silver stained (<I>left panels</I>, <I>Proteins</I>) and
autoradiographed (<I>right panels</I>, <SUP><I>32</I></SUP><I>P</I>).
Positions of molecular mass markers are indicated on the
<I>left</I>, and the hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> position is indicated by an
<I>arrowhead</I> (<I>right</I>). Note that electrophoresis
conditions were slightly different for mutants S157A and S388A,
explaining the observed different mobility for labeled polypeptides of
~25 and 18&nbsp;kDa.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 3 -->







<BR CLEAR=ALL><A NAME="F4"><!-- FIG 4 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/274/53/38225/F4">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=52 SRC="/content/vol274/issue53/images/small/bc0103913004.gif"></A><BR>

<STRONG>View larger version</STRONG> (21K):
<BR><NOBR><A HREF="/cgi/content/full/274/53/38225/F4">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/274/53/38225/F4"
onClick="startTarget('F4', 590, 315); this.href='/cgi/content-nw/full/274/53/38225/F4'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F4">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 4. &nbsp;</STRONG>

<B>Localization of phosphorylated serine 157&nbsp;in
hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> domain D.</B>&nbsp;Sequence alignment of
hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">1, hRAR<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">2, hRAR<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">2, hRXR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">, and hRXR<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 is shown. The
phosphorylated serine are located in the D domain (amino acids 153-198
of hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">) and map to the T box (amino acids 154-165), a region
involved in receptor dimerization and DNA binding. The NCoR box maps to
the COOH terminus of domain D from residue 181&nbsp;to residue 198.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 4 -->







    

    


<P><I>Converting Serine 157&nbsp;into Aspartic Acid Decreases Transcriptional
Activity of hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">--</I>

To examine the role of this phosphorylatable
amino acid in regulating the transcriptional activity of hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">, we
constructed<SUP> </SUP>eukaryotic expression vectors encoding Ser to Ala or Gly,
and<SUP> </SUP>Ser to Asp hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> mutants, either to prevent constitutive
phosphorylation<SUP> </SUP>by PKC</A> (Ser to Ala/Gly mutants) or to mimic the net
charge increase<SUP> </SUP>brought by phosphorylation (Ser to Asp mutants). As for
<I>in vitro</I><SUP> </SUP>experiments, we deliberately mutated all potential
phosphorylation<SUP> </SUP>sites for PKC</A> (Ser-115, Ser-157, Ser-232, Ser-388, and
Ser-452)<SUP> </SUP>and compared the activity of Ser to Ala and of Ser to Asp
mutants<SUP> </SUP>with that of the wt</A> hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">. HeLa cells express low levels of
RARs<SUP> </SUP>and RXRs which are able to activate prototypical retinoid response<SUP> </SUP>elements such as the direct repeat found in the RAR<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">2 gene promoter<SUP> </SUP>(DR5). To avoid any interference with endogenous receptors, we<SUP> </SUP>used the
luciferase reporter gene driven by the synthetic, palindromic<SUP> </SUP>thyroid
response element TREpal, which is also activated by retinoids<SUP> </SUP>but
necessitates high levels of receptors which are only achieved<SUP> </SUP>upon
transfection of RAR</A> and/or RXR</A> expression vectors (<A HREF="#B17">17</A>,<SUP> </SUP><A HREF="#B25">25</A>). We thus
monitored the transcriptional activity of Ser to<SUP> </SUP>Ala and of Ser to Asp
mutants in the presence of hRXR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> in this<SUP> </SUP>system and compared them
with the activity of wt</A> hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">, using<SUP> </SUP>atRA</A> as an inducer at a
10<SUP><IMG SRC="/math/12pt/normal/scr/minus.gif" ALIGN=BASELINE ALT="-">6</SUP> <font size=-1>M</font> final concentration (Fig.
<a href="#F5">5</a>). The basal level of luciferase<SUP> </SUP>activity measured in the presence of wt</A> hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> or mutant receptors<SUP> </SUP>did
not fluctuate significantly, suggesting that these receptors<SUP> </SUP>have a
similar affinity for nuclear corepressors. <I>In vitro</I>
protein-protein<SUP> </SUP>interaction assays revealed that all of these receptors
bound<SUP> </SUP>to the nuclear corepressor SMRT</A> with a wt</A>
affinity.<A HREF="#FN3"><SUP>3</SUP></A> The addition of atRA</A>
to the culture medium leads typically to<SUP> </SUP>a 5-10-fold increase in
luciferase activity: only two mutations<SUP> </SUP>affected the ability of hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">
to respond to atRA</A>, S115G and S157D,<SUP> </SUP>although both receptors were
expressed at levels comparable to<SUP> </SUP>that of wt</A> hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">.<SUP>3</SUP>
S115G activity decreased by 30% compared with wt</A> hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">. Because<SUP> </SUP>Ser-115 is not phosphorylated by PKCs (Fig. <a href="#F3">3</a>), and S115D displayed<SUP> </SUP>a
wt</A> activity, it is likely that the observed decreased activity<SUP> </SUP>results
from structural alterations of the DBD</A> and not from direct<SUP> </SUP>phosphorylation. Ser-115 is indeed located between the two zinc<SUP> </SUP>fingers
of hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">, and mutations at this position in the hVDR sequence<SUP> </SUP>(S51)
were proposed to alter the <IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">-helical structure of this region<SUP> </SUP>(<A HREF="#B8">8</A>). A
decrease of at least 50% was observed in atRA-induced<SUP> </SUP>luciferase
activity in cells overexpressing S157D, whereas S157A<SUP> </SUP>retained wt</A>
activity, consistent with our working hypothesis of<SUP> </SUP>a PKC-mediated
inactivation of hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">. The latter observation also<SUP> </SUP>suggests that no
phosphorylation of Ser-157 occurs in nonstimulated<SUP> </SUP>cells, in agreement
with a previous report (<A HREF="#B27">27</A>). We also note<SUP> </SUP>that this decrease in
activity is similar to that observed upon<SUP> </SUP>chronic treatment of cells
with TPA</A> (<A HREF="#B14">14</A>), and therefore identify<SUP> </SUP>Ser-157 as a functional substrate
for PKCs.



<BR CLEAR=ALL><A NAME="F5"><!-- FIG 5 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/274/53/38225/F5">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=126 SRC="/content/vol274/issue53/images/small/bc0103913005.gif"></A><BR>

<STRONG>View larger version</STRONG> (39K):
<BR><NOBR><A HREF="/cgi/content/full/274/53/38225/F5">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/274/53/38225/F5"
onClick="startTarget('F5', 590, 478); this.href='/cgi/content-nw/full/274/53/38225/F5'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F5">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 5. &nbsp;</STRONG>

<B>Comparison of the transcriptional activities
of hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> mutants in HeLa cells.</B> HeLa cells
were cotransfected with (TREpal)TATA<SUB>3</SUB>Luc, pSG<SUB>5</SUB>
wt</A> hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">, or mutants and pSG<SUB>5</SUB>hRXR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">. Basal and
ligand-induced activities of the (TREpal)<SUB>3</SUB> luciferase
reporter gene are represented as <I>bar chart</I> for each mutant,
in the presence (<I>atRA</I></A>) or absence (<I>basal</I>) of 1&nbsp;&#181;<font size=-1>M</font> atRA</A>. Each mutant activity was assayed when
overexpressed together with hRXR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">, thus reflecting heterodimeric RAR</A>
activity. The average luciferase activity from at least six experiments
(&#177;&nbsp;S.E.) is given for each mutant, with the level of luciferase
activity of wt</A> hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> observed in the presence of 1&nbsp;&#181;<font size=-1>M</font>
atRA</A> taken as 100%. * <I>p</I>&nbsp;=&nbsp;0.01; **<I>p</I>&nbsp;=&nbsp;0.04.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 5 -->







    

    


<P><I>Phosphorylation of Serine 157&nbsp;Decreases the Ability of hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> to
Heterodimerize with RXR--</I>

The effects of the Ser-157 mutation on
RAR</A> properties were investigated: the ability of the mutated receptor
to bind natural<SUP> </SUP>and synthetic ligands, its subcellular localization in
response<SUP> </SUP>to ligand as well as its half-life, its interaction with
nuclear<SUP> </SUP>corepressor (SMRT</A>) and coactivators (SRC-1</A>, RIP140</A>) were
tested.<SUP> </SUP>None of these assays revealed functional alterations of the
receptor.<SUP>3</SUP> The ability of the receptor to interact with RXR</A>
in a ligand-dependent<SUP> </SUP>manner in the absence of DNA was
quantified in glutathione <I>S</I>-transferase<SUP> </SUP>pull-down
experiments (Fig. <a href="#F6">6</a>). A Sepharose GST-RXR
affinity matrix<SUP> </SUP>was used as a bait for <SUP>35</SUP>S-labeled wt</A>
hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> and receptor mutants S157A and S157D, in the<SUP> </SUP>presence or not of
1&nbsp;&#181;<font size=-1>M</font> atRA</A>. Similar amounts of receptors were<SUP> </SUP>used in each
condition and high salt washes allowed to monitor<SUP> </SUP>the ligand-induced
stabilization of RAR-RXR interaction. Heterodimer<SUP> </SUP>formation was
stimulated 3-fold for wt</A> hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> and the S157A mutant<SUP> </SUP>(Fig.
<a href="#F6">6</a><I>A</I>). S157D displayed a slightly but significantly decreased<SUP> </SUP>constitutive dimerization (in the absence of atRA</A>) and a 2-fold<SUP> </SUP>reduction in its ability to dimerize with RXR</A> in the presence<SUP> </SUP>of atRA</A>.
This result was confirmed using an independent assay<SUP> </SUP>in which
phosphorylated or native His-tagged RAR</A> was immobilized<SUP> </SUP>on a
hydrophobic matrix (<A HREF="#B8">8</A>). <SUP>35</SUP>S-Labeled RXR</A> was then incubated,
in the presence of 1&nbsp;&#181;<font size=-1>M</font> atRA</A>,<SUP> </SUP>with this matrix, and
specifically bound receptors were quantified<SUP> </SUP>(Fig. <a href="#F6">6</a><I>B</I>). RAR</A>
phosphorylation by PKC</A>, in conditions where more<SUP> </SUP>than 80% of the
receptor was phosphorylated by PKCs, led to a<SUP> </SUP>50% decrease in RXR</A>
retention on this matrix, in agreement with<SUP> </SUP>results generated by the
glutathione <I>S</I>-transferase pull-down assay.<SUP> </SUP>Thus to a 50%
decreased transcriptional activity is associated<SUP> </SUP>with a decreased
ability to form a dimer with hRXR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">, strongly<SUP> </SUP>suggesting that
PKC-catalyzed post-translational modification<SUP> </SUP>of hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> is controlling
the ability of RAR</A> to heterodimerize with<SUP> </SUP>RXR</A>.



<BR CLEAR=ALL><A NAME="F6"><!-- FIG 6 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/274/53/38225/F6">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=127 HEIGHT=200 SRC="/content/vol274/issue53/images/small/bc0103913006.gif"></A><BR>

<STRONG>View larger version</STRONG> (27K):
<BR><NOBR><A HREF="/cgi/content/full/274/53/38225/F6">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/274/53/38225/F6"
onClick="startTarget('F6', 430, 640); this.href='/cgi/content-nw/full/274/53/38225/F6'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F6">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 6. &nbsp;</STRONG>

<B>hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">
heterodimerization with hRXR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> is
inhibited by phosphorylation of serine 157.</B>&nbsp;<I>Panel A</I>,
<SUP>35</SUP>S-Labeled hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> polypeptides were produced by <I>in
vitro</I> coupled transcription-translation, incubated for 2&nbsp;h
with dimethyl sulfoxide or 1&nbsp;&#181;<font size=-1>M</font> atRA</A>, and adsorbed on a
Sepharose-GST-hRXR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> affinity matrix. Bound receptors were resolved by
SDS-PAGE and quantified by PhosphorImager analysis. Results are shown
as the average of three independent experiments (&#177;&nbsp;S.D.) and are
presented with a typical autoradiogram. Results from analysis were
normalized for translation efficiency using the protein input lane as a
reference (which represents 20% of total input) and expressed as the
ratio of bound receptor to 20% input protein. <I>Panel B</I>,
purified wt</A> hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> was submitted to a phosphorylation reaction in the
presence of rat brain purified PKCs, ATP in the presence or not of a
specific inhibitor (100&nbsp;n<font size=-1>M</font> GF109203X) and adsorbed to
microtiter wells. After extensive washing to remove unbound ATP,
10<SUP>6</SUP> cpm of <SUP>35</SUP>S-labeled hRXR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> was added to the
wells and incubated for 2&nbsp;h with 1&nbsp;&#181;<font size=-1>M</font> atRA</A>. Bound
material was quantified by scintillation counting, and the results are
expressed as means&nbsp;&#177;&nbsp;S.D. of three independent experiments.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 6 -->







    


    


    
    


<BR><BR CLEAR=ALL>


<A NAME="SEC3"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;DISCUSSION</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">RESULTS</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>DISCUSSION</FONT>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    
    <P>Modulation of the phosphorylation state plays an important role in
the reversible control of the activity of many proteins,<SUP> </SUP>including
nuclear receptors. In the case of hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">1, heterodimerization<SUP> </SUP>properties have been shown to be altered by protein phosphatases<SUP> </SUP>1&nbsp;and
2A (<A HREF="#B15">15</A>) and the NH<SUB>2</SUB>-terminal function AF-1 to be activated<SUP> </SUP>through the proline-directed Cdk7 (<A HREF="#B27">27</A>). We now show that dimerization<SUP> </SUP>of hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> with hRXR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> can be modulated by PKC-dependent
phosphorylation.<SUP> </SUP>Several potential phosphorylation sites by PKCs are
located along<SUP> </SUP>the hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> sequence. Phosphopeptide mapping studies as
well as<SUP> </SUP>mutagenesis of hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> identified Ser-157 as the major target
for<SUP> </SUP>PKC<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> and PKC<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma "> isoforms (Figs. <a href="#F2">2</a> and <a href="#F3">3</a>). This amino acid is
located<SUP> </SUP>in the T box of hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">, which, together with the A box, are
part<SUP> </SUP>of a larger region (hinge domain) that is organized into an
<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">-helical<SUP> </SUP>structure in the RXR&#183;T<SUB>3</SUB>R</A> DBD</A> dimer (<A HREF="#B23">23</A>).
Molecular modeling<SUP> </SUP>of RXR&#183;RAR</A> dimers suggested that the T box,
forming a loop interrupted<SUP> </SUP>by an <IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">-helical turn perpendicular to the
DNA axis, engages dimerization<SUP> </SUP>contacts with the RXR</A> DBD</A>.
Interestingly, Ser-157 neighbors amino<SUP> </SUP>acids that, in
RXR&#183;T<SUB>3</SUB>R</A> and RXR&#183;VDR</A> dimer structures, establish<SUP> </SUP>salt
bridges with the RXR</A> DBD</A> (Asp-69 and Glu-69, respectively).<SUP> </SUP>Thus
phosphorylation of Ser-157 may introduce strong conformational<SUP> </SUP>constraints on this dimerization region and, as observed, decrease<SUP> </SUP>the
relative affinity of RAR</A> DBD</A> for RXR</A> DBD</A> and inhibit dimerization.<SUP> </SUP>Alternatively, phosphorylation of Ser-157 may perturb the relative<SUP> </SUP>orientation of RAR</A> DBD</A> and LBD</A> as suggested for VDR</A> (<A HREF="#B24">24</A>) and<SUP> </SUP>in turn
modify the orientation of the strong dimerization interface<SUP> </SUP>located in
the hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> LBD</A> (<A HREF="#B8">8</A>). Protein kinases C are a family<SUP> </SUP>of Ser/Thr kinases
whose activities are involved in the regulation<SUP> </SUP>of complex biological
responses such as differentiation, proliferation,<SUP> </SUP>and apoptosis. They
are organized in two domains, a COOH-terminal<SUP> </SUP>catalytic domain and an
NH<SUB>2</SUB> -terminal regulatory domain. Their<SUP> </SUP>tissue distribution
is in most cases ubiquitous, with the exception<SUP> </SUP>of PKC<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">, which is
expressed specifically in the brain and spinal<SUP> </SUP>cord. Response to
agonists (hormones, neurotransmitters, growth<SUP> </SUP>factors) is mediated
through a transient short term production<SUP> </SUP>of DAG</A>, essentially through
phosphatidylinositol 4,5-bisphosphate<SUP> </SUP>hydrolysis. A more sustained
response may be observed with phosphatidylcholine<SUP> </SUP>hydrolysis or phorbol
ester treatment. The basic model of PKC</A><SUP> </SUP>activation suggests that PKC</A>
translocation to the plasma membrane<SUP> </SUP>is the main event regulating this
signaling cascade. However,<SUP> </SUP>PKC</A> is often found, irrespective of its
activation state, in the<SUP> </SUP>particulate fraction (membranes, organelles,
and nuclei) of cultured<SUP> </SUP>cells and in nuclei themselves. HeLa cells were
found to express<SUP> </SUP><IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">, <IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">, <IMG SRC="/math/12pt/normal/iota.gif" ALIGN=BASELINE ALT="iota ">, &#181;, <IMG SRC="/math/12pt/normal/lambda.gif" ALIGN=BASELINE ALT="lambda ">, and <IMG SRC="/math/12pt/normal/zeta.gif" ALIGN=BASELINE ALT="zeta ">&nbsp;isozymes, among which
<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">&nbsp;and <IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">&nbsp;isozymes appeared<SUP> </SUP>to be sensitive to TPA-induced
down-regulation.<SUP>3</SUP> Both PKC<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> and <IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">&nbsp;can be found in
nuclei of HeLa cells.<SUP>3</SUP> A prolonged activation of PKCs by
phorbol esters or repeated<SUP> </SUP>DAG</A> stimulation leads to cellular depletion
in PKCs by inducing<SUP> </SUP>a high rate of proteolytic clipping of
DAG-dependent kinases,<SUP> </SUP>concomitantly with the nuclear
translocation of the catalytic<SUP> </SUP>domain (PKM), which displays unregulated
kinase activity (<A HREF="#B28">28</A>).<SUP> </SUP>We observed that the catalytic domain of PKC<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">
and <IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">&nbsp;(PKM) was<SUP> </SUP>almost exclusively nuclear and that PKM accumulated
in nuclei<SUP> </SUP>upon TPA</A> treatment, to reach a 3-5-fold higher concentration
than<SUP> </SUP>in control cells.<SUP>3</SUP> However, this treatment, much like
PKC<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> overexpression, also<SUP> </SUP>led to strong alteration of the cellular
morphology as well as<SUP> </SUP>perturbation of the cell cycle, and therefore
made a direct correlation<SUP> </SUP>between PKC</A> activation/translocation and
hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> inhibition very<SUP> </SUP>difficult to establish. However, in these types
of experiments,<SUP> </SUP>S157A displayed a very low sensitivity to TPA</A>
treatment, in opposition<SUP> </SUP>to wt</A> hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">.<SUP>3</SUP> Several nuclear
proteins are potential or known substrates for<SUP> </SUP>PKCs: LIM-containing
proteins (<A HREF="#B29">29</A>), p53 (<A HREF="#B30">30</A>), WT1 (<A HREF="#B31">31</A>),<SUP> </SUP>c-myc (<A HREF="#B32">32</A>), and nuclear receptors
such as T<SUB>3</SUB>R</A> (<A HREF="#B6">6</A>), VDR</A> (<A HREF="#B7">7</A>),<SUP> </SUP>RAR</A> (14&nbsp;and this report) and
RXR</A>.<SUP>2</SUP> PKC</A> activation has been reported to inhibit
VDR-controlled transcription<SUP> </SUP>(<A HREF="#B33">33</A>) through a mechanism involving direct
phosphorylation of<SUP> </SUP>the DBD</A> (<A HREF="#B8">8</A>). RAR-mediated transactivation has also
been reported<SUP> </SUP>to be strongly potentiated by short term phorbol ester
treatment<SUP> </SUP>in T cells (<A HREF="#B34">34</A>). However, similar experiments carried out in<SUP> </SUP>HeLa cells demonstrated a strong inhibition of the atRA-induced<SUP> </SUP>transcriptional response, in agreement with the proposed inhibition<SUP> </SUP>of
the retinoid pathway by the AP-1 signaling
module.<A HREF="#FN4"><SUP>4</SUP></A> It is therefore likely
that the reported potentiation arises<SUP> </SUP>from an AP-1 independent,
cell-type specific indirect<SUP> </SUP>mechanism.
    
    </P>

    
    <P>atRA has been described as an effector able to modulate PKC</A> isozymes
expression (<A HREF="#B35">35-38</A>) and/or PKC</A> subcellular repartition<SUP> </SUP>in several cell
lines (<A HREF="#B39">39</A>, <A HREF="#B40">40</A>). However, our data neither<SUP> </SUP>provided evidence for
significant variation of PKC</A> isoform content<SUP> </SUP>in atRA-treated cells, nor
we were able to document alteration<SUP> </SUP>of the cellular partitioning of
expressed intact isoforms by indirect<SUP> </SUP>immunofluorescence.<SUP>3</SUP>
This set of data clearly suggests that interferences between<SUP> </SUP>the PKC</A>
and retinoid signaling pathways are cell-specific and<SUP> </SUP>diverse and that,
in this respect, one must distinguish between<SUP> </SUP>short term events (AP-1
induction, PKC</A> activation) and long term<SUP> </SUP>events (alteration of PKC</A>
expression rate). Short term TPA</A> treatment<SUP> </SUP>of HeLa cells may activate
several signaling pathways involving<SUP> </SUP>PKCs, MAP</A> kinases, and c-Jun
NH<SUB>2</SUB>-terminal kinase (JNK). PKC</A> down-regulation<SUP> </SUP>has been
reported to block completely JNK activation by phorbol<SUP> </SUP>esters in HeLa
cells (<A HREF="#B41">41</A>), and MAP</A> kinase overexpression in<SUP> </SUP>COS cells did not modify
the phosphorylation pattern of hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUP> </SUP>(<A HREF="#B27">27</A>). No increase in MAP</A> kinase
activity was detected in TPA-treated<SUP> </SUP>HeLa cells,<SUP>3</SUP> thus
ruling out a potential involvement of these two protein<SUP> </SUP>kinases in the
observed inactivation of hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">.
    
    </P>

    
    <P>Furthermore, additional cross-talk processes can be also considered
based on the nongenomic effects of steroid and of others<SUP> </SUP>ligands for
nuclear receptors. For example, vitamin D3 has been<SUP> </SUP>shown to activate
the MAP</A> kinase signaling cascade through activation<SUP> </SUP>of PKC</A> (<A HREF="#B42">42</A>) and is
able to induce subcellular redistribution<SUP> </SUP>of
calcium-dependent PKCs. Tamoxifen, a
therapeutic/chemopreventive<SUP> </SUP>nonsteroidal antagonist of estrogen
receptor, induces PKC</A> translocation<SUP> </SUP>to the membrane and down-regulation
of this enzyme through oxidative<SUP> </SUP>stress (<A HREF="#B43">43</A>). Finally, retinoids,
estrogens, and vitamin D3 treatment<SUP> </SUP>of cells modulate the rate of
expression of PKC</A> isoforms (<A HREF="#B26">26</A>,<SUP> </SUP><A HREF="#B44">44-46</A>), underlining a complex network
of intertwined, and often<SUP> </SUP>antagonistic, signaling pathways eventually
controlling cell differentiation,<SUP> </SUP>growth, and<SUP> </SUP>death.
    
    </P>

    
    <P>In conclusion, our findings establish that PKC</A> isoforms are able to
phosphorylate hRAR<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> and control its dimerization properties,<SUP> </SUP>very
likely through T box conformational alteration. The observed<SUP> </SUP>inhibition
may be of importance in differentiation and proliferation<SUP> </SUP>processes
during which sustained activation of PKCs is necessary<SUP> </SUP>to induce a full
biological response to external<SUP> </SUP>stimuli.
    
    


<BR><BR CLEAR=ALL>

</TXT>



<!-- Stray figures and tables -->


<!-- Acknowledgements -->

<!-- Notes -->


<!-- Footnotes -->

<A NAME="foo"><!-- comment for mosaic --></A>

<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;FOOTNOTES</FONT></TH>
</TR>
</TABLE>



<P><A NAME="FN150"><SUP>*</SUP></A>
This work was supported in part by grants from INSERM, Ligue
Nationale contre le Cancer, and Association pour la Recherche<SUP> </SUP>sur le
Cancer. INSERM U 459&nbsp;is part of IFR 22&nbsp;(INSERM, Centre<SUP> </SUP>Hospitalier
R&eacute;gional Universitaire, Centre Oscar Lambret, and<SUP> </SUP>University of
Lille 2).The costs of publication of this
article<SUP> </SUP>were defrayed in part by the
payment of page charges. The article<SUP> </SUP>must therefore be hereby marked
"<I>advertisement</I>" in
accordance<SUP> </SUP>with 18&nbsp;U.S.C. Section
1734&nbsp;solely to indicate this<SUP> </SUP>fact.

<P>
<P><A NAME="FN152"><SUP><IMG SRC="/math/12pt/normal/scr/Dagger.gif" ALIGN=BASELINE ALT="Dagger "></SUP></A>
Supported by a fellowship from R&eacute;gion Nord-Pas de Calais and<SUP> </SUP>CHRU.

<P>
<P><A NAME="FN153"><SUP>&#167;</SUP></A>
Present address: Laboratory of Developmental Genetics, Rockefeller
University, 1230&nbsp;York Ave., New York NY<SUP> </SUP>10021.

<P>
<P><A NAME="FN154"><SUP>&#182;</SUP></A>
To whom correspondence should be addressed. Tel.:
33-3-2062-6887; Fax: 33-3-2062-6884; E-mail:
p.lefebvre@lille.inserm.fr.

<P>


<P><A NAME="FN2"><SUP>2</SUP></A>
A. Tahayato, P.&nbsp;Formstecher, and P.&nbsp;Lefebvre,
unpublished<SUP> </SUP>data.

<P>
<P><A NAME="FN3"><SUP>3</SUP></A>
M.-H. Delmotte and P.&nbsp;Lefebvre, unpublished<SUP> </SUP>data.

<P>
<P><A NAME="FN4"><SUP>4</SUP></A>
M.-H. Delmotte, M.&nbsp;Benkoussa, and P.&nbsp;Lefebvre,
unpublished<SUP> </SUP>data.

<P>

<A NAME="abb"><!-- comment for mosaic --></A>

<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ABBREVIATIONS</FONT></TH>
</TR>
</TABLE>

<P>The abbreviations used are: 

DAG, diacylglycerol;

PKC, protein kinase C;

VDR, vitamin D3 receptor;

h, human;

DBD, DNA
binding domain;

MAP, mitogen-activated protein;

TPA, 12-<I>O</I>-tetradecanoylphorbol-13-acetate;

LBD, ligand binding
domain;

wt, wild-type;

RAR, retinoic acid receptor;

RXR, 9-<I>cis-</I>retinoic acid receptor;

atRA, all<I>-trans-</I>retinoic acid;

PAGE, polyacrylamide gel
electrophoresis;

GST, glutathione <I>S</I>-transferase;

T<SUB>3</SUB>R, thyroid hormone receptor;

SMRT, silencing mediator of
RAR and T<SUB>3</SUB>R;

RIP140, 140-kDa receptor interacting protein;

SRC-1, steroid receptor coactivator-1.

</P>


<!-- Appendices -->

<!-- Bibliography -->




<A NAME="References"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;REFERENCES</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">DISCUSSION</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>REFERENCES</FONT>
</FONT></TH>
</TR></TABLE>

<BR CLEAR=ALL>
<TABLE BORDER=0>
<TR><TD VALIGN=TOP><a name="B1">1.</a>
    <TD VALIGN=TOP>

Nishizuka, Y.



(1992)

<I>Science</I>
<B>258</B>,
607-614<!-- HIGHWIRE ID="274:53:38225:1" --><A HREF="/cgi/external_ref?access_num=1411571&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=1411571&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B2">2.</a>
    <TD VALIGN=TOP>

Nishizuka, Y.



(1995)

<I>FASEB J.</I>
<B>9</B>,
484-496<!-- HIGHWIRE ID="274:53:38225:2" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=fasebj&resid=9/7/484">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B3">3.</a>
    <TD VALIGN=TOP>

Blobe, G. C.,
Stribling, S.,
Obeid, L. M.,
 and Hannun, Y. A.



(1996)

<I>Cancer Surv.</I>
<B>27</B>,
213-248<!-- HIGHWIRE ID="274:53:38225:3" --><A HREF="/cgi/external_ref?access_num=8909803&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8909803&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B4">4.</a>
    <TD VALIGN=TOP>

Jaken, S.



(1996)

<I>Curr. Opin. Cell Biol.</I>
<B>8</B>,
168-173<!-- HIGHWIRE ID="274:53:38225:4" --><A HREF="/cgi/external_ref?access_num=10.1016/S0955-0674(96)80062-7&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=8791416&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8791416&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B5">5.</a>
    <TD VALIGN=TOP>

Hofmann, J.



(1997)

<I>FASEB J.</I>
<B>11</B>,
649-669<!-- HIGHWIRE ID="274:53:38225:5" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=fasebj&resid=11/8/649">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B6">6.</a>
    <TD VALIGN=TOP>

VI,
Goldberg, Y.,
Glineur, C.,
Gesquiere, J. C.,
Ricouart, A.,
Sap, J.,
Vennstrom, B.,
 and Ghysdael, J.



(1988)

<I>EMBO J.</I>
<B>7</B>,
2425-2433<!-- HIGHWIRE ID="274:53:38225:6" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=emboj&resid=7/8/2425">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B7">7.</a>
    <TD VALIGN=TOP>

Hsieh, J. C.,
Jurutka, P. W.,
Galligan, M. A.,
Terpening, C. M.,
Haussler, C. A.,
Samuels, D. S.,
Shimizu, Y.,
Shimizu, N.,
 and Haussler, M. R.



(1991)

<I>Proc. Natl. Acad. Sci. U.&nbsp;S.&nbsp;A.</I>
<B>88</B>,
9315-9319<!-- HIGHWIRE ID="274:53:38225:7" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=88/20/9315">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B8">8.</a>
    <TD VALIGN=TOP>

Hsieh, J. C.,
Jurutka, P. W.,
Nakajima, S.,
Galligan, M. A.,
Haussler, C. A.,
Shimizu, Y.,
Shimizu, N.,
Whitfield, G. K.,
 and Haussler, M. R.



(1993)

<I>J. Biol. Chem.</I>
<B>268</B>,
15118-15126<!-- HIGHWIRE ID="274:53:38225:8" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=268/20/15118"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B9">9.</a>
    <TD VALIGN=TOP>

Ueda, Y.,
Hirai, S.-i,
Osada, S.-i,
Suzuki, A.,
Mizuno, K.,
 and Ohno, S.



(1996)

<I>J. Biol. Chem.</I>
<B>271</B>,
23512-23519<!-- HIGHWIRE ID="274:53:38225:9" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=271/38/23512"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B10">10.</a>
    <TD VALIGN=TOP>

Schonwasser, D. C.,
Marais, R. M.,
Marshall, C. J.,
 and Parker, P. J.



(1998)

<I>Mol. Cell. Biol.</I>
<B>18</B>,
790-798<!-- HIGHWIRE ID="274:53:38225:10" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=mcb&resid=18/2/790"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B11">11.</a>
    <TD VALIGN=TOP>

Krstic, M. D.,
Rogatsky, I.,
Yamamoto, K. R.,
 and Garabedian, M. J.



(1997)

<I>Mol. Cell. Biol.</I>
<B>17</B>,
3947-3954<!-- HIGHWIRE ID="274:53:38225:11" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=mcb&resid=17/7/3947">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B12">12.</a>
    <TD VALIGN=TOP>

Hu, E. D.,
Kim, J. B.,
Sarraf, P.,
 and Spiegelman, B. M.



(1996)

<I>Science</I>
<B>274</B>,
2100-2103<!-- HIGHWIRE ID="274:53:38225:12" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=sci&resid=274/5295/2100"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B13">13.</a>
    <TD VALIGN=TOP>

Kato, S.,
Endoh, H.,
Masuhiro, Y.,
Kitamoto, T.,
Uchiyama, S.,
Sasaki, H.,
Masushige, S.,
Gotoh, Y.,
Nishida, E.,
Kawashima, H.,
Metzger, D.,
 and Chambon, P.



(1995)

<I>Science</I>
<B>270</B>,
1491-1494<!-- HIGHWIRE ID="274:53:38225:13" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=sci&resid=270/5241/1491">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B14">14.</a>
    <TD VALIGN=TOP>

Tahayato, A.,
Lefebvre, P.,
Formstecher, P.,
 and Dautrevaux, M.



(1993)

<I>Mol. Endocrinol.</I>
<B>7</B>,
1642-1653<!-- HIGHWIRE ID="274:53:38225:14" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=mend&resid=7/12/1642">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B15">15.</a>
    <TD VALIGN=TOP>

Lefebvre, P.,
Gaub, M. P.,
Tahayato, A.,
Rochette-Egly, C.,
 and Formstecher, P.



(1995)

<I>J. Biol. Chem.</I>
<B>270</B>,
10806-10816<!-- HIGHWIRE ID="274:53:38225:15" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=270/18/10806"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B16">16.</a>
    <TD VALIGN=TOP>

Rachez, C.,
Sautiere, P.,
Formstecher, P.,
 and Lefebvre, P.



(1996)

<I>J. Biol. Chem.</I>
<B>271</B>,
17996-18006<!-- HIGHWIRE ID="274:53:38225:16" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=271/30/17996"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B17">17.</a>
    <TD VALIGN=TOP>

Lefebvre, B.,
Mouchon, A.,
Formstecher, P.,
 and Lefebvre, P.



(1998)

<I>Biochemistry</I>
<B>37</B>,
9240-9249<!-- HIGHWIRE ID="274:53:38225:17" --><A HREF="/cgi/external_ref?access_num=10.1021/bi9804840&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9649304&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9649304&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B18">18.</a>
    <TD VALIGN=TOP>

Tahayato, A.,
Rachez, C.,
Formstecher, P.,
 and Lefebvre, P.



(1997)

in 
<I>Retinoid Protocols</I>


 (Redfern, C., ed)
, pp. 277-291, Humana Press Inc., Totowa, NJ
    <!-- HIGHWIRE ID="274:53:38225:18" --><!-- /HIGHWIRE --></TR>
<TR><TD VALIGN=TOP><a name="B19">19.</a>
    <TD VALIGN=TOP>

Mouchon, A.,
Delmotte, M.-H.,
Formstecher, P.,
 and Lefebvre, P.



(1999)

<I>Mol. Cell. Biol.</I>
<B>19</B>,
3073-3085<!-- HIGHWIRE ID="274:53:38225:19" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=mcb&resid=19/4/3073"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B20">20.</a>
    <TD VALIGN=TOP>

Bradford, M. M.



(1976)

<I>Anal. Biochem.</I>
<B>72</B>,
248-54<!-- HIGHWIRE ID="274:53:38225:20" --><A HREF="/cgi/external_ref?access_num=10.1006/abio.1976.9999&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=942051&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=942051&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B21">21.</a>
    <TD VALIGN=TOP>

Dutil, E. M.,
Toker, A.,
 and Newton, A. C.



(1998)

<I>Curr. Biol.</I>
<B>8</B>,
1366-1375<!-- HIGHWIRE ID="274:53:38225:21" --><A HREF="/cgi/external_ref?access_num=9889098&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9889098&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B22">22.</a>
    <TD VALIGN=TOP>

Martiny-Baron, G.,
Kazanietz, M. G.,
Misschak, H.,
Blumberg, P. M.,
Kochs, G.,
Hug, G.,
Marme, D.,
 and Schachtele, C.



(1993)

<I>Proc. Natl. Acad. Sci. U.&nbsp;S.&nbsp;A.</I>
<B>268</B>,
9194-9197<!-- HIGHWIRE ID="274:53:38225:22" --><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B23">23.</a>
    <TD VALIGN=TOP>

Rastinejad, F.,
Perlmann, T.,
Evans, R. M.,
 and Sigler, P. B.



(1995)

<I>Nature</I>
<B>375</B>,
203-211<!-- HIGHWIRE ID="274:53:38225:23" --><A HREF="/cgi/external_ref?access_num=7746322&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=7746322&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B24">24.</a>
    <TD VALIGN=TOP>

Quack, M.,
Szafranski, K.,
Rouvinen, J.,
 and Carlberg, C.



(1998)

<I>Nucleic Acids Res.</I>
<B>26</B>,
5372-5378<!-- HIGHWIRE ID="274:53:38225:24" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=nar&resid=26/23/5372"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B25">25.</a>
    <TD VALIGN=TOP>

Zhang, X. K.,
Salbert, G.,
Lee, M. O.,
 and Pfahl, M.



(1994)

<I>Mol. Cell. Biol.</I>
<B>14</B>,
4311-4323<!-- HIGHWIRE ID="274:53:38225:25" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=mcb&resid=14/6/4311">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B26">26.</a>
    <TD VALIGN=TOP>

Simboli-Campbell, M.,
Gagnon, A.,
Franks, D. J.,
 and Welsh, J.



(1994)

<I>J. Biol. Chem.</I>
<B>269</B>,
3257-3264<!-- HIGHWIRE ID="274:53:38225:26" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=269/5/3257"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B27">27.</a>
    <TD VALIGN=TOP>

Rochette-Egly, C.,
Adam, S.,
Rossignol, M.,
Egly, J. M.,
 and Chambon, P.



(1997)

<I>Cell</I>
<B>90</B>,
97-107<!-- HIGHWIRE ID="274:53:38225:27" --><A HREF="/cgi/external_ref?access_num=9230306&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9230306&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B28">28.</a>
    <TD VALIGN=TOP>

James, G.,
 and Olson, E. N.



(1992)

<I>J. Cell Biol.</I>
<B>116</B>,
863-874<!-- HIGHWIRE ID="274:53:38225:28" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jcb&resid=116/4/863">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B29">29.</a>
    <TD VALIGN=TOP>

Kuroda, S.,
Tokunaga, C.,
Kiyohara, Y.,
Higuchi, O.,
Konishi, H.,
Mizuno, K.,
Gill, G. N.,
 and Kikkawa, U.



(1996)

<I>J. Biol. Chem.</I>
<B>271</B>,
31029-31032<!-- HIGHWIRE ID="274:53:38225:29" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=271/49/31029"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B30">30.</a>
    <TD VALIGN=TOP>

Chernov, M. V.,
Ramana, C. V.,
Adler, V. V.,
 and Stark, G. R.



(1998)

<I>Proc. Natl. Acad. Sci. U.&nbsp;S.&nbsp;A.</I>
<B>95</B>,
2284-2289<!-- HIGHWIRE ID="274:53:38225:30" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=95/5/2284"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B31">31.</a>
    <TD VALIGN=TOP>

Ye, Y.,
Raychaudhuri, B.,
Gurney, A.,
Campbell, C. E.,
 and Williams, B. R.



(1996)

<I>EMBO J.</I>
<B>15</B>,
5606-5615<!-- HIGHWIRE ID="274:53:38225:31" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=emboj&resid=15/20/5606">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B32">32.</a>
    <TD VALIGN=TOP>

Pollok, K. E.,
 and Snow, E. C.



(1991)

<I>Cell Signal.</I>
<B>3</B>,
435-452<!-- HIGHWIRE ID="274:53:38225:32" --><A HREF="/cgi/external_ref?access_num=1760254&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=1760254&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B33">33.</a>
    <TD VALIGN=TOP>

Krishnan, A. V.,
 and Feldman, D.



(1991)

<I>Mol. Endocrinol.</I>
<B>5</B>,
605-612<!-- HIGHWIRE ID="274:53:38225:33" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=mend&resid=5/4/605">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B34">34.</a>
    <TD VALIGN=TOP>

Yang, Y. L.,
Minucci, S.,
Zand, D. J.,
Ozato, K.,
 and Ashwell, J. D.



(1994)

<I>Mol. Endocrinol.</I>
<B>8</B>,
1370-1376<!-- HIGHWIRE ID="274:53:38225:34" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=mend&resid=8/10/1370">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B35">35.</a>
    <TD VALIGN=TOP>

Khuri, F. R.,
Cho, Y. H.,
 and Talmage, D. A.



(1996)

<I>Cell Growth Differ.</I>
<B>7</B>,
595-602<!-- HIGHWIRE ID="274:53:38225:35" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=cellgd&resid=7/5/595">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B36">36.</a>
    <TD VALIGN=TOP>

Kindregan, H. C.,
Rosenbaum, S. E.,
Ohno, S.,
 and Niles, R. M.



(1994)

<I>J. Biol. Chem.</I>
<B>269</B>,
27756-27761<!-- HIGHWIRE ID="274:53:38225:36" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=269/44/27756"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B37">37.</a>
    <TD VALIGN=TOP>

Gruber, J. R.,
Ohno, S.,
 and Niles, R. M.



(1992)

<I>J. Biol. Chem.</I>
<B>267</B>,
13356-13360<!-- HIGHWIRE ID="274:53:38225:37" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=267/19/13356"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B38">38.</a>
    <TD VALIGN=TOP>

Rosewicz, S.,
Brembeck, F.,
Kaiser, A.,
Marschall, Z. V.,
 and Riecken, E. O.



(1996)

<I>Endocrinology</I>
<B>137</B>,
3340-3347<!-- HIGHWIRE ID="274:53:38225:38" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=endo&resid=137/8/3340">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B39">39.</a>
    <TD VALIGN=TOP>

Kurie, J. M.,
Younes, A.,
Miller, W. H.,
Burchert, M.,
Chiu, C. F.,
Kolesnick, R.,
 and Dmitrovsky, E.



(1993)

<I>Biochim. Biophys. Acta</I>
<B>1179</B>,
203-207<!-- HIGHWIRE ID="274:53:38225:39" --><A HREF="/cgi/external_ref?access_num=8218362&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8218362&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B40">40.</a>
    <TD VALIGN=TOP>

Cho, Y. H.,
Tighe, A. P.,
 and Talmage, D. A.



(1997)

<I>J. Cell. Physiol.</I>
<B>172</B>,
306-313<!-- HIGHWIRE ID="274:53:38225:40" --><A HREF="/cgi/external_ref?access_num=10.1002/(SICI)1097-4652(199709)172:3<306::AID-JCP4>3.0.CO;2-S&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9284950&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9284950&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B41">41.</a>
    <TD VALIGN=TOP>

Werlen, G.,
Jacinto, E.,
Xia, Y.,
 and Karin, M.



(1998)

<I>EMBO J.</I>
<B>17</B>,
3101-3111<!-- HIGHWIRE ID="274:53:38225:41" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=emboj&resid=17/11/3101"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B42">42.</a>
    <TD VALIGN=TOP>

Beno, D. W.&nbsp;A.,
Brady, L. M.,
Bissonnette, M.,
 and Davis, B. H.



(1995)

<I>J. Biol. Chem.</I>
<B>270</B>,
3642-3647<!-- HIGHWIRE ID="274:53:38225:42" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=270/8/3642"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B43">43.</a>
    <TD VALIGN=TOP>

Gundimeda, U.,
Chen, Z. H.,
 and Gopalakrishna, R.



(1996)

<I>J. Biol. Chem.</I>
<B>271</B>,
13504-13514<!-- HIGHWIRE ID="274:53:38225:43" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=271/23/13504"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B44">44.</a>
    <TD VALIGN=TOP>

Marino, M.,
Pallottini, V.,
 and Trentalance, A.



(1998)

<I>Biochem. Biophys. Res. Commun.</I>
<B>245</B>,
254-258<!-- HIGHWIRE ID="274:53:38225:44" --><A HREF="/cgi/external_ref?access_num=10.1006/bbrc.1998.8413&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9535818&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9535818&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B45">45.</a>
    <TD VALIGN=TOP>

Berry, D. M.,
Antochi, R.,
Bhatia, M.,
 and Meckling-Gill, K. A.



(1996)

<I>J. Biol. Chem.</I>
<B>271</B>,
16090-16096<!-- HIGHWIRE ID="274:53:38225:45" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=271/27/16090"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B46">46.</a>
    <TD VALIGN=TOP>

Lissoos, T. W.,
Beno, D. W.&nbsp;A.,
 and Davis, B. H.



(1993)

<I>J. Biol. Chem.</I>
<B>268</B>,
25132-25138<!-- HIGHWIRE ID="274:53:38225:46" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=268/33/25132"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>

</TABLE>



<P><HR>
<FONT SIZE=-1><A HREF="/misc/terms.shtml"><B>Copyright &#169; 1999 by The American Society for Biochemistry and Molecular Biology, Inc.</B></A></FONT>




<!--

   Pages created by the Electronic Press Engine from

		Atypon Systems, Inc.

   Visit http://www.atypon.com/

-->


</vardef>

		
        
        
	
	
	



 




<BR CLEAR=ALL>




<A NAME="otherarticles"><!-- null --></A>
<P>
<FONT SIZE=+2><STRONG>This article has been cited by other articles:</STRONG></FONT>
<P>




<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	G. Boskovic, D. Desai, and R. M. Niles<BR>
	<STRONG>Regulation of Retinoic Acid Receptor alpha  by Protein Kinase C in B16 Mouse Melanoma Cells</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        July&nbsp;19,&nbsp;2002;
	277(29):
	26113 - 26119.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/277/29/26113">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/277/29/26113">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/277/29/26113">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.biolreprod.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.biolreprod.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.biolreprod.org"><IMG ALT="Biol Reprod" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/biolreprod.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	K. W. Braun, M.-N. Vo, and K. H. Kim<BR>
	<STRONG>Positive Regulation of Retinoic Acid Receptor Alpha by Protein Kinase C and Mitogen-Activated Protein Kinase in Sertoli Cells</STRONG><BR>
	
		
			Biol. Reprod.,
		
	
        
        July&nbsp;1,&nbsp;2002;
	67(1):
	29 - 37.
<BR>
<A HREF="http://www.biolreprod.org/cgi/content/abstract/67/1/29">[Abstract]</A>

<A HREF="http://www.biolreprod.org/cgi/content/full/67/1/29">[Full Text]</A>
<A HREF="http://www.biolreprod.org/cgi/reprint/67/1/29">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://mcb.asm.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://mcb.asm.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://mcb.asm.org"><IMG ALT="Mol. Cell. Biol." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/mcb.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	M. Benkoussa, C. Brand, M.-H. Delmotte, P. Formstecher, and P. Lefebvre<BR>
	<STRONG>Retinoic Acid Receptors Inhibit AP1 Activation by Regulating Extracellular Signal-Regulated Kinase and CBP Recruitment to an AP1-Responsive Promoter</STRONG><BR>
	
		
			Mol. Cell. Biol.,
		
	
        
        July&nbsp;1,&nbsp;2002;
	22(13):
	4522 - 4534.
<BR>
<A HREF="http://mcb.asm.org/cgi/content/abstract/22/13/4522">[Abstract]</A>

<A HREF="http://mcb.asm.org/cgi/content/full/22/13/4522">[Full Text]</A>
<A HREF="http://mcb.asm.org/cgi/reprint/22/13/4522">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://mend.endojournals.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://mend.endojournals.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://mend.endojournals.org"><IMG ALT="Mol Endocrinol" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/mend.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	F. Gay, P. Barath, C. Desbois-Le Peron, R. Metivier, R. Le Guevel, D. Birse, and G. Salbert<BR>
	<STRONG>Multiple Phosphorylation Events Control Chicken Ovalbumin Upstream Promoter Transcription Factor I Orphan Nuclear Receptor Activity</STRONG><BR>
	
		
			Mol. Endocrinol.,
		
	
        
        June&nbsp;1,&nbsp;2002;
	16(6):
	1332 - 1351.
<BR>
<A HREF="http://mend.endojournals.org/cgi/content/abstract/16/6/1332">[Abstract]</A>

<A HREF="http://mend.endojournals.org/cgi/content/full/16/6/1332">[Full Text]</A>
<A HREF="http://mend.endojournals.org/cgi/reprint/16/6/1332">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://emboreports.npgjournals.com"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://emboreports.npgjournals.com/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://emboreports.npgjournals.com"><IMG ALT="EMBO Reports" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/emborep.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	B. Lefebvre, K. Ozato, and P. Lefebvre<BR>
	<STRONG>Phosphorylation of histone H3 is functionally linked to retinoic acid receptor {beta} promoter activation</STRONG><BR>
	
		
			EMBO Rep.,
		
	
        
        April&nbsp;15,&nbsp;2002;
	3(4):
	335 - 340.
<BR>
<A HREF="http://emboreports.npgjournals.com/cgi/content/abstract/3/4/335">[Abstract]</A>

<A HREF="http://emboreports.npgjournals.com/cgi/content/full/3/4/335">[Full Text]</A>
<A HREF="http://emboreports.npgjournals.com/cgi/reprint/3/4/335">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://nar.oupjournals.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://nar.oupjournals.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://nar.oupjournals.org"><IMG ALT="Nucleic Acids Res" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/nar.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	A. Parrado, G. Despouy, R. Kraiba, C. L. Pogam,  S. Dupas, M. Choquette, M. Robledo, J. Larghero,  H. Bui, I. L. Gall, C. Rochette-Egly, C. Chomienne, and  R. A. Padua<BR>
	<STRONG>Retinoic acid receptor {alpha}1 variants, RAR{alpha}1{Delta}B and RAR{alpha}1{Delta}BC, define a new class of nuclear receptor isoforms</STRONG><BR>
	
		
			Nucleic Acids Res.,
		
	
        
        December&nbsp;15,&nbsp;2001;
	29(24):
	4901 - 4908.
<BR>
<A HREF="http://nar.oupjournals.org/cgi/content/abstract/29/24/4901">[Abstract]</A>

<A HREF="http://nar.oupjournals.org/cgi/content/full/29/24/4901">[Full Text]</A>
<A HREF="http://nar.oupjournals.org/cgi/reprint/29/24/4901">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	P. M. Barger, A. C. Browning, A. N. Garner, and D. P. Kelly<BR>
	<STRONG>p38 Mitogen-activated Protein Kinase Activates Peroxisome Proliferator-activated Receptor alpha . A POTENTIAL ROLE IN THE CARDIAC METABOLIC STRESS RESPONSE</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        November&nbsp;30,&nbsp;2001;
	276(48):
	44495 - 44501.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/276/48/44495">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/276/48/44495">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/276/48/44495">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	C. Depoix, M.-H. Delmotte, P. Formstecher, and P. Lefebvre<BR>
	<STRONG>Control of Retinoic Acid Receptor Heterodimerization by Ligand-induced Structural Transitions. A NOVEL MECHANISM OF ACTION FOR RETINOID ANTAGONISTS</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        March&nbsp;16,&nbsp;2001;
	276(12):
	9452 - 9459.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/276/12/9452">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/276/12/9452">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/276/12/9452">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>










<BR CLEAR=ALL>
<BR CLEAR=ALL>


	
	 
		  
			                    
	


	
		<!-- beginning of outer tables -->
               
                
                <TABLE CELLPADDING=4
                ALIGN=RIGHT
                
                CELLPADDING=5 HSPACE=4 VSPACE=4 BORDER NOWRAP>
               
		<TR><TD ALIGN=LEFT NOWRAP>

		<!-- beginning of inner table -->
				<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
		
		
	 
	
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/content/abstract/274/53/38225">Abstract of this Article</A>  (<img src="/icons/shared/toc/free.gif">)
			</FONT></TD></TR>
		
		
	


		
		
		

		
		
		


		
		
		

		
		
		

		
		
		

		
                
                

		
	


		

		
	

		
		

		
		 

		
		 
	 		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">

			
			 

			
			

						
				
				<STRONG><A HREF="/cgi/reprint/274/53/38225">Reprint (PDF) Version of this Article</A>
 				
			

			

		</FONT></TD></TR>
		
		


                
                


		


	



		



		
		

		
		
		
	


		


		

		

		
		
			
			
			
				<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/citemap?id=jbc;274/53/38225">Citation Map</A>
				</FONT></TD></TR>
		


		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/mailafriend?url=http://www.jbc.org/cgi/content/full/274/53/38225&title=Serine+157%2C+a+Retinoic+Acid+Receptor+alpha++Residue+Phosphorylated+by+Protein+Kinase+C+in+Vitro%2C+Is+Involved+in+RXR%7Bmiddle+dot%7DRARalpha++Heterodimerization+and+Transcriptional+Activity">Email this article to a friend</A>
		</FONT></TD></TR>
		


		 
		
		


	
	
	
	
		
		
		
		
	
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			Similar articles found in:<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/search?qbe=jbc;274/53/38225&journalcode=jbc&minscore=5000"><FONT SIZE="-1">JBC Online</FONT></A>
				
				
				<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/external_ref?access_num=10608897&link_type=MED_NBRS"><FONT SIZE="-1">PubMed</FONT></A>
		</FONT></TD></TR>
		
		
	
	
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/external_ref?access_num=10608897&link_type=PUBMED">PubMed Citation</A>
	</FONT></TD></TR>
	
	

		
		
		
		
		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				This Article has been cited by:
			</FONT></TD></TR>
		

		
		
		


                
                


                
                

		
		
		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		
			Search PubMed for articles by:<BR>
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">
			
				<A HREF="/cgi/external_ref?access_num=Delmotte+MH&link_type=AUTHORSEARCH">Delmotte, M.-H.</A>
				 || 
			
				<A HREF="/cgi/external_ref?access_num=Lefebvre+P&link_type=AUTHORSEARCH">Lefebvre, P.</A>
				
			
		
		</FONT></TD></TR>
		

		
		



		



		


		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		Alert me when:
		<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&saveAlert=no&cited_by_criteria_resid=jbc;274/53/38225&return_type=article&return_url=%2Fcgi%2Fcontent%2Ffull%2F274%2F53%2F38225"><FONT SIZE="-1">new articles cite this article</FONT></A><BR>
		</FONT></TD></TR>


		


		
		


		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			<A HREF="/cgi/citmgr?gca=jbc;274/53/38225">Download to Citation Manager</A>
		</FONT></TD></TR>
		
		

		
		</TABLE> 
		</TD></TR> <!-- end of inner content box -->




		
		
		
		


		
        <!-- 1xxx --><!-- 2xxx --><!-- 3xxx -->
        
	</TABLE>	 <!-- end of outer content box -->
	


					
	

<BR CLEAR=ALL>

        
	<P>
	<HR NOSHADE ALIGN="LEFT" WIDTH="450" SIZE="1">
	
	<TABLE CELLPADDING="2" CELLSPACING="2" WIDTH="450">
	<TR>
		<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HOME</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/help/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HELP</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/cgi/feedback"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">FEEDBACK</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/subscriptions/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SUBSCRIPTIONS</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/contents-by-date.0.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">ARCHIVE</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/search.dtl"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SEARCH</FONT></A></TD>
	    


<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/content/vol274/issue53/index.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">TABLE OF CONTENTS</FONT></A></TD>




	</TR>
	</TABLE>
	
	


	
<TABLE CELLPADDING="2" CELLSPACING="2" BORDER="0">
<TR>
        <TD BGCOLOR="#006699" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.asbmb.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">All ASBMB Journals</A></STRONG>&nbsp;</TD>
        <TD BGCOLOR="#CC0000" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.mcponline.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Molecular and Cellular Proteomics</A></STRONG>&nbsp;</TD>
</TR><TR>
        <TD BGCOLOR="#0099FF" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.jlr.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Journal of Lipid Research</A></STRONG>&nbsp;</TD>
        <TD BGCOLOR="#003F77" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.bambed.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Biochemistry and Molecular Biology Education</A></STRONG>&nbsp;</TD>
</TR>
</TABLE>

	<FONT SIZE="-1"><STRONG><A TARGET="_top" HREF="/misc/terms.shtml">Copyright &copy; 1999 by the American Society for Biochemistry and Molecular Biology.</A></STRONG></FONT>
	


</BODY>
</HTML>
